menu

PARENT PAGES: PHILOSOPHY

Why Invest Discussion

GreyBird Investment Opportunities In spite of growing R&D expenditures, truly new technologies are not coming from the largest multi-national diagnostic technology companies. They are coming from entrepreneurs, who are creating an appetite for M&A. The demand for our portfolio is already here.   Industry Dynamics Poor development productivity Lack of organic growth Risk reduction M&A initiatives Scientific Discovery ‘Omics revolution New detection technologies Targeted therapies Personal monitoring devices Advanced analytics Healthcare Economics Access vs. cost control Global structural growth Global clinical trials Unnecessary, ineffective, and inefficient care avoidance   We will improve health and create wealth, by investing in technologies...

READ MORE
Why Invest Intro

Why Invest in Precision Diagnostics

READ MORE
Precision Medicine Discussion

All healthcare starts with diagnosis. Diagnostics for precision medicine must: Provide specific characterization of an individual patient’s unique disease and biology. Accurately identify individual patients who will and who will not respond to therapies that are increasingly targeted and increasingly expensive. Create an environment for an efficient healthcare system. GreyBird has the goal to invest in companies that can help to eliminate “trial and error” medicine with high-specificity diagnostics and generate value for patients, providers, developers of therapies, and those who pay for healthcare.   For every patient that they help, the ten highest grossing drugs in the United States...

READ MORE
Precision Medicine Intro

Precision Medicine and Precision Diagnostics

READ MORE
Contact

For additional information, please contact: greybird@greybirdventures.com DISCLAIMER   GreyBird Ventures LLC (“GreyBird”) has prepared the contents of this web site (“Site”) solely for informational purposes and to assist prospective investors who view this Site (the “Recipients”) in deciding whether to proceed with a further investigation of investments managed by GreyBird. Under no circumstances shall this Site be deemed or construed to be an offer to sell, or the solicitation of an offer to buy, any securities, and it is not intended to be the basis of any investment decision or any decision to subscribe to a GreyBird investment vehicle (“Investments”)....

READ MORE
About GreyBird

GreyBird Ventures is named after the arctic tern, a bird that migrates 71,000 km annually. As they can live for 30 years, this is the lifetime equivalent of three trips to the moon and back. Not bad for a 100 gram bird. We strive to emulate its size to performance ratio as well as its global reach. MEET THE PEOPLE

READ MORE
GreyBird Ventures

is named after the arctic tern, a bird that migrates 71,000 km annually. As they can live for 30 years, this is the lifetime equivalent of three trips to the moon and back. Not bad for a 100 gram bird. We strive to emulate its size to performance ratio as well as its global reach.

MEET THE PEOPLE

For additional information, please contact: greybird@greybirdventures.com

DISCLAIMER